Skip to main content
. 2020 Oct 13;890:173642. doi: 10.1016/j.ejphar.2020.173642

Table 1.

Target SARS-CoV-2 main protease in apo form with Remdesivir drug used in study.

Protein/Drug Structure Source
SARS-CoV-2 (main protease in apo form) Image 2 https://www.rcsb.org/structure/6M03
Remdesivir drug[C27H35N6O8P] Image 3 https://www.drugbank.ca/drugs/DB14761